Resistance-modifying agents.: Part 7:: 2, 6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of α1-acid glycoprotein (AGP)

被引:10
作者
Barlow, HC
Bowman, KJ
Curtin, NJ
Calvert, AH
Golding, BT
Huang, B
Loughlin, PJ
Newell, DR
Smith, PG
Griffin, RJ
机构
[1] Univ Newcastle Upon Tyne, Dept Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Med Sch Newcastle Upon Tyne, Canc Res Unit, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
D O I
10.1016/S0960-894X(00)00053-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biological evaluation of potent 4,8-dibenzylaminopyrimidopyrimidine nucleoside transport inhibitors, with reduced binding to alpha(1)-acid glycoprotein, is reported. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:585 / 589
页数:5
相关论文
共 19 条
[1]  
BELT JA, 1993, ADV ENZYME REGUL, V33, P235
[2]  
BUDD GT, 1990, CANCER RES, V50, P7206
[3]  
Buolamwini JK, 1997, CURR MED CHEM, V4, P35
[4]   Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α1-acid glycoprotein binding [J].
Curtin, NJ ;
Bowman, KJ ;
Turner, RN ;
Huang, B ;
Loughlin, PJ ;
Calvert, AH ;
Golding, BT ;
Griffin, RJ ;
Newell, DR .
BRITISH JOURNAL OF CANCER, 1999, 80 (11) :1738-1746
[5]   MODULATION OF DIPYRIDAMOLE ACTION BY ALPHA-1-ACID GLYCOPROTEIN - REDUCED POTENTIATION OF QUINAZOLINE ANTIFOLATE (CB3717) CYTO-TOXICITY BY DIPYRIDAMOLE [J].
CURTIN, NJ ;
NEWELL, DR ;
HARRIS, AL .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (19) :3281-3288
[6]   NUCLEOSIDE SALVAGE AND RESISTANCE TO ANTIMETABOLITE ANTICANCER AGENTS [J].
FOX, M ;
BOYLE, JM ;
KINSELLA, AR .
BRITISH JOURNAL OF CANCER, 1991, 64 (03) :428-436
[7]  
GOEL R, 1992, NEW DRUGS CONCEPTS R, P19
[8]   Folate-based thymidylate synthase inhibitors as anticancer drugs [J].
Jackman, AL ;
Calvert, AH .
ANNALS OF ONCOLOGY, 1995, 6 (09) :871-881
[9]   MODULATION OF ANTI-METABOLITE EFFECTS - EFFECTS OF THYMIDINE ON THE EFFICACY OF THE QUINAZOLINE-BASED THYMIDYLATE SYNTHETASE INHIBITOR, CB3717 [J].
JACKMAN, AL ;
TAYLOR, GA ;
CALVERT, AH ;
HARRAP, KR .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (20) :3269-3275
[10]  
KREMER JMH, 1988, PHARMACOL REV, V40, P1